Magnera ended fiscal 2026 with higher adjusted earnings and strong cash generation, despite weaker volumes in several markets. The materials maker reported a fourth-quarter operating loss and a full-year operating loss, both including $106 million of goodwill and other impairment charges.
For fiscal 2027, Magnera expects adjusted EBITDA of $390 million to $410 million and free cash flow of $110 million to $130 million. It says its priorities include profitable growth and further productivity and cost improvements.
Fourth-quarter results
- Net sales were $851 million, up 1% from $839 million a year earlier. Higher selling prices added $43 million, largely reflecting the pass-through of higher raw-material costs, but organic volumes fell 4%.
- The volume decline reflected softer healthcare demand in the Americas and continued general market weakness in Europe.
- Adjusted EBITDA rose 8% to $97 million from $90 million. Magnera attributed the improvement primarily to a $9 million favorable price-cost spread.
- The GAAP operating loss was $90 million, compared with operating income of $10 million a year earlier. The 2026 loss included $106 million of goodwill and other impairment.
Full-year results
- Fiscal 2026 net sales were $3.296 billion, up 3% from $3.204 billion. On a comparable basis—which adjusts for foreign currency and recent merger activity—sales declined 4%.
- Adjusted EBITDA increased 7% to $378 million from $354 million; on a comparable basis, it rose 4%.
- The GAAP operating loss was $37 million, versus operating income of $5 million in fiscal 2025. The 2026 result included the $106 million impairment charge.
- Cash from operations was $178 million. After $63 million of net additions to property, plant and equipment, free cash flow was $115 million. Magnera said that equated to a free-cash-flow yield of more than 25% of its market capitalization at fiscal year-end.
- The company repaid $122 million of debt during the year, including $57 million in the fourth quarter, as it focuses on strengthening its credit metrics.
Regional and operating trends
- In the Americas, higher selling prices added $19 million to sales, while organic volumes declined 2%. Adjusted EBITDA improved, with Magnera citing a $4 million favorable price-cost spread and benefits from Project CORE and merger synergies.
- In the Rest of World segment, sales were essentially flat: a $24 million increase in selling prices was offset by a 6% organic volume decline. Adjusted EBITDA improved, helped by a $5 million favorable price-cost spread and cost and synergy benefits, partly offset by lower volumes.
- Across the business, Magnera said Project CORE, merger synergies and operational improvements supported cost reductions and profitability. It also cited inflationary pressures and changing demand across its end markets.
Fiscal 2027 outlook
- Adjusted EBITDA: $390 million to $410 million.
- Free cash flow: $110 million to $130 million.
The results show a contrast between weak reported operating income, weighed down by impairment charges, and higher adjusted EBITDA and substantial cash generation. Magnera is directing a significant portion of that cash toward debt repayment while continuing its cost and productivity initiatives.
